Smoothing the Bumpy Road to Antiarrhythmic Drug Development

Affiliations

¹ From the Manchester Royal Infirmary, Manchester, United Kingdom (V.M.R.); Lankenau Institute for Medical Research, Philadelphia, PA (V.M.R., P.R.K.); and Jefferson Medical College, Philadelphia, PA (P.R.K.).
² From the Manchester Royal Infirmary, Manchester, United Kingdom (V.M.R.); Lankenau Institute for Medical Research, Philadelphia, PA (V.M.R., P.R.K.); and Jefferson Medical College, Philadelphia, PA (P.R.K.). koweyp@mlhs.org.

Editorial

Victoria M Robinson et al. Circulation. 2015.

. 2015 Dec 8;132(23):2195-7.

doi: 10.1161/CIRCULATIONAHA.115.019463. Epub 2015 Oct 23.

¹ From the Manchester Royal Infirmary, Manchester, United Kingdom (V.M.R.); Lankenau Institute for Medical Research, Philadelphia, PA (V.M.R., P.R.K.); and Jefferson Medical College, Philadelphia, PA (P.R.K.).
² From the Manchester Royal Infirmary, Manchester, United Kingdom (V.M.R.); Lankenau Institute for Medical Research, Philadelphia, PA (V.M.R., P.R.K.); and Jefferson Medical College, Philadelphia, PA (P.R.K.). koweyp@mlhs.org.

No abstract available

Keywords: Editorials; anti-arrhythmia agents; atrial fibrillation; computers; ion channels.

Comment on

Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M, Xiong F, Qi XY, Comtois P, Nattel S. Aguilar M, et al. Circulation. 2015 Dec 8;132(23):2203-11. doi: 10.1161/CIRCULATIONAHA.115.018016. Epub 2015 Oct 23. Circulation. 2015. PMID: 26499964